Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q2FY24 of ₹2,660.00 Crores up from ₹2,291.00 Crore year on year, a rise of 16.11%.
Total Expenses for Q2FY24 of ₹2,127.00 Crores up from ₹1,844.00 Crores year on year, a rise of 15.35%.
Consolidated Net Profit of ₹386.00 Crores up 23.72% from ₹312.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.41, up 23.75% from ₹9.22 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.